Medicine & Life Sciences

1. Breast Neoplasms 100%
2. Centrosome 79%
3. Aurora Kinase A 74%
4. MLN 8237 41%
5. Chromosomal Instability 39%
6. Neoplasms 35%
7. Epithelial-Mesenchymal Transition 27%
8. Glycogen Synthase Kinase 3 23%
9. Sirolimus 23%
10. Triple Negative Breast Neoplasms 22%
11. Neoplasm Metastasis 21%
12. Heterografts 21%
13. Estrogen Receptors 19%
14. Centrioles 16%
15. DNA Damage 15%
16. Phosphatidylinositol 3-Kinases 14%
17. Therapeutics 14%
18. Cell Line 13%
19. Mitogen-Activated Protein Kinase Kinases 13%
20. Induced Pluripotent Stem Cells 13%
21. Drug Resistance 12%
22. Cell Cycle 12%
23. cardiotrophin 1 12%
24. Sulfamethoxazole Drug Combination Trimethoprim 12%
25. G1 Phase Cell Cycle Checkpoints 11%
26. Phenotype 11%
27. progesterone receptor B 11%
28. OSM-LIF Receptors 11%
29. DEAD-box RNA Helicases 11%
30. Oncolytic Virotherapy 11%
31. Estrogen Receptor alpha 10%
32. estrophilin 10%
33. Cyclin-Dependent Kinase 2 10%
34. Estradiol 10%
35. Mechanistic Target of Rapamycin Complex 1 9%
36. Endothelin A Receptors 9%
37. Fulvestrant 9%
38. Organoids 9%
39. Phosphotransferases 9%
40. Measles virus 9%
41. Catenins 9%
42. Proline 9%
43. Neoplastic Stem Cells 8%
44. Acetylation 8%
45. MCF-7 Cells 8%
46. Inflammatory Breast Neoplasms 8%
47. Teratoma 8%
48. Measles 8%
49. Bevacizumab 8%
50. Genomic Instability 8%